Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaebok Choi

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Developmental Biology|June 14, 2006
N-ethylmaleimide sensitive factor is required for fusion of the C. elegans uterine anchor cellJaebok Choi, Keri L Richards, Hediye Nese Cinar, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2017
OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral bloodKarl W Staser, William Eades, Jaebok Choi, et al.
Plos One|November 20, 2018
Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantationBader Alahmari, Matthew Cooper, Edward Ziga, et al.
Cell Transplantation|May 17, 2013
Effect of epigallocatechin-3-gallate on graft-versus-host diseaseJaebok Choi, Matthew L Cooper, Edward D Ziga, et al.
Plos One|October 8, 2014
Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effectJaebok Choi, Matthew L Cooper, Bader Alahmari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2017
Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In VivoMatthew L Cooper, Jaebok Choi, Darja Karpova, et al.
Therapeutic Advances in Hematology|June 16, 2020
Insights into the role of the JAK/STAT signaling pathway in graft-<i>versus</i>-host diseaseRamzi Abboud, Jaebok Choi, Peter Ruminski, et al.
Leukemia|March 11, 2020
Selective targeting of α4β1 integrin attenuates murine graft versus host diseaseBader Alahmari, Matthew L Cooper, Kiran Vij, et al.
Developmental Cell|May 10, 2007
AFF-1, a FOS-1-regulated fusogen, mediates fusion of the anchor cell in C. elegansAmir Sapir, Jaebok Choi, Evgenia Leikina, et al.
Molecules (Basel, Switzerland)|April 27, 2024
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse ModelSena Kim, Peter Ruminski, Megh Singh, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Developmental Biology|June 14, 2006
N-ethylmaleimide sensitive factor is required for fusion of the C. elegans uterine anchor cellJaebok Choi, Keri L Richards, Hediye Nese Cinar, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2017
OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral bloodKarl W Staser, William Eades, Jaebok Choi, et al.
Plos One|November 20, 2018
Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantationBader Alahmari, Matthew Cooper, Edward Ziga, et al.
Cell Transplantation|May 17, 2013
Effect of epigallocatechin-3-gallate on graft-versus-host diseaseJaebok Choi, Matthew L Cooper, Edward D Ziga, et al.
Plos One|October 8, 2014
Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effectJaebok Choi, Matthew L Cooper, Bader Alahmari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2017
Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In VivoMatthew L Cooper, Jaebok Choi, Darja Karpova, et al.
Therapeutic Advances in Hematology|June 16, 2020
Insights into the role of the JAK/STAT signaling pathway in graft-<i>versus</i>-host diseaseRamzi Abboud, Jaebok Choi, Peter Ruminski, et al.
Leukemia|March 11, 2020
Selective targeting of α4β1 integrin attenuates murine graft versus host diseaseBader Alahmari, Matthew L Cooper, Kiran Vij, et al.
Developmental Cell|May 10, 2007
AFF-1, a FOS-1-regulated fusogen, mediates fusion of the anchor cell in C. elegansAmir Sapir, Jaebok Choi, Evgenia Leikina, et al.
Molecules (Basel, Switzerland)|April 27, 2024
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse ModelSena Kim, Peter Ruminski, Megh Singh, et al.
Pageof 4